BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 21, 2026
See today's BioWorld
Home
» Other news to note for Sept. 9, 2020
To read the full article
sign up for free
or
sign in
.
Other news to note for Sept. 9, 2020
Sep. 9, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Ascletis, Asia Green, Atomwise, Berg, Biontech, Biopharma-Middle East and Africa, Caladrius, Chromadex, Cleave, Datavant, Eveliqure, Galmed, GC Pharma, Gigagen, Global Blood Therapeutics Inc., Ibio, Inveniai, Jazz, Johnson & Johnson, Lexicon, Lineage, Merck, Modulus, Monopar, Nkmax, Noden, Ocugen, Otsuka, Pathway, PDL, Pfizer, PNW, Presage, Prism, Redx, SXT, Takeda, Tersera, Tscan, Valneva, Versatope.
BioWorld
Briefs
Other news to note
Coronavirus